OBJECTIVE: Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related, in part, not to Native American genetic admixture but to Spanish genetic admixture. RESEARCH DESIGN AND METHODS: Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose > or =7.0 mmol/l or 2-h glucose > or =11.1 mmol/l or use of antidiabetic agents. RESULTS: A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain (6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip ratio. CONCLUSIONS: The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations.
OBJECTIVE: Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related, in part, not to Native American genetic admixture but to Spanish genetic admixture. RESEARCH DESIGN AND METHODS: Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose > or =7.0 mmol/l or 2-h glucose > or =11.1 mmol/l or use of antidiabetic agents. RESULTS: A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain (6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip ratio. CONCLUSIONS: The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations.
Authors: Kendra A Young; Tasha E Fingerlin; Carl D Langefeld; Carlos Lorenzo; Steven M Haffner; Lynne E Wagenknecht; Jill M Norris Journal: Ethn Dis Date: 2012 Impact factor: 1.847
Authors: Javier Gayán; José J Galan; Antonio González-Pérez; María Eugenia Sáez; María Teresa Martínez-Larrad; Carina Zabena; M Carmen Rivero; Ana Salinas; Reposo Ramírez-Lorca; Francisco J Morón; Jose Luis Royo; Concha Moreno-Rey; Juan Velasco; José M Carrasco; Eva Molero; Carolina Ochoa; María Dolores Ochoa; Marta Gutiérrez; Mercedes Reina; Rocío Pascual; Alejandro Romo-Astorga; Juan Luis Susillo-González; Enrique Vázquez; Luis M Real; Agustín Ruiz; Manuel Serrano-Ríos Journal: BMC Genomics Date: 2010-05-25 Impact factor: 3.969
Authors: Lindsay A Uribe; Peter Bacchetti; Nicholas Gelman; Esteban Burchard; Mark Fitch; Marc Hellerstein; Mandana Khalili Journal: Alcohol Clin Exp Res Date: 2018-02-01 Impact factor: 3.455
Authors: Barbora Vozarova; José-Manuel Fernández-Real; William C Knowler; Lluis Gallart; Robert L Hanson; Jonathan D Gruber; Wilfredo Ricart; Joan Vendrell; Cristóbal Richart; P Antonio Tataranni; Johanna K Wolford Journal: Hum Genet Date: 2003-02-14 Impact factor: 4.132
Authors: Antonio Grilo; Elena S Ruiz-Granados; Concha Moreno-Rey; Jose M Rivera; Agustin Ruiz; Luis M Real; Maria E Sáez Journal: Gene Date: 2013-03-21 Impact factor: 3.688
Authors: María E Sáez; Antonio González-Pérez; María T Martínez-Larrad; Javier Gayán; Luis M Real; Manuel Serrano-Ríos; Agustín Ruiz Journal: BMC Med Genet Date: 2010-10-14 Impact factor: 2.103